Doing it our way now: the approach this company pioneered is becoming the market's way
The model's full reasoning — Q3 2023 call → NOWe need to determine if management describes that their way of doing things is being adopted by others in the market. The transcript discusses their COVID vaccine, combination vaccine, Matrix-M adjuvant, etc. They mention that their technology is validated, but do they say others are following? They mention that their combination vaccine is a priority, and they are moving to Phase 3. They mention that they have a protein-based non-mRNA option. They don't explicitly say competitors are copying them. They mention that they are seeing market share, but not that others are adopting their approach. They mention that their vaccine is the only protein-based non-mRNA option, but that doesn't imply others are following. They mention that they have a favorable reactogenicity profile, but no mention of others adopting. They mention that Matrix-M is used in other vaccines, but that's their own product. They don't describe others moving toward their way. So answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| AES | The AES Corporation | Q1 2024 | 2024-05-03 | C+ |
| GGR | Gogoro Inc. | Q1 2023 | 2023-05-11 | D |
| TGT | Target Corporation | Q4 2022 | 2023-02-28 | C |
| ORAN | Orange SA | Q2 2018 | 2018-07-26 | B |
| USFD | US Foods Holding Corp. | Q1 2018 | 2018-05-12 | C |
| SHOO | Steven Madden, Ltd. | Q1 2017 | 2017-04-21 | C |
AES · Q1 2024 → YESThe question is: Does management describe that the WAY THIS COMPANY DOES THINGS is NOW BEING ADOPTED, COPIED, OR MOVED TOWARD BY OTHERS IN ITS MARKET, so that the company's own way of doing things is ...
GGR · Q1 2023 → YESThe question is: Does management describe that the way this company does things is now being adopted, copied, or moved toward by others in its market?
TGT · Q4 2022 → YESThe question is: Does management describe that the way this company does things is now being adopted, copied, or moved toward by others in its market?